Embecta Corp

EMBC Small Cap

Healthcare · Medical Instruments & Supplies

Updated: Apr 5, 2026, 17:43 UTC

$8.85

+0.68% today

52W: $8.47 – $15.55

52W Low: $8.47 Position: 5.4% 52W High: $15.55

🔗 Compare Brokers

Key Metrics

P/E Ratio

3.75x

Price-to-Earnings

Forward P/E

3.07x

Forward Price/Earnings

P/S Ratio

0.49x

Price-to-Sales

EV/EBITDA

4.73x

Enterprise Value/EBITDA

Div. Yield

679%

Annual dividend yield

Market Cap

$524.1M

Market Capitalization

Revenue Growth

-0.3%

YoY Revenue Growth

Profit Margin

12.92%

Net profit margin

ROE

—

Return on Equity

Beta

1.1

Market sensitivity

Short Interest

11.31%

% of float sold short

Avg. Volume

846,154

Average daily volume

Valuation Analysis

Signal

Undervalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

3 analysts

Avg. Price Target

$16.67

+88.32% upside

Target Range

$11.00 – $25.00

About the Company

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Sector: Healthcare Industry: Medical Instruments & Supplies Country: United States Employees: 1,850 Exchange: NMS